Final report on NCCTG N0877 (Alliance): a phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma 2025

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial 2023

Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival 2020

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool 2018

New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163 2008

The past, current and future management of brain metastases in EGFR-mutant non-small cell lung cancer [editorial].  23. 2021